Lataa...
Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells
BACKGROUND: Metformin is an oral anti-diabetic agent that has been widely prescribed for treatment of type II diabetes. Anti-cancer properties of metformin have been revealed for numerous human malignancies including cholangiocarcinoma (CCA) with anti-proliferative effects in vitro. However, effects...
Tallennettuna:
| Julkaisussa: | Asian Pac J Cancer Prev |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
West Asia Organization for Cancer Prevention
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5454745/ https://ncbi.nlm.nih.gov/pubmed/28345832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.2.473 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|